Technical Analysis for SLP - Simulations Plus, Inc.

Grade Last Price % Change Price Change
grade A 24.61 -0.28% -0.07
SLP closed down 0.28 percent on Monday, May 20, 2019, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical SLP trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
New 52 Week High Strength 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish -0.28%
New 52 Week High Strength -0.28%
Overbought Stochastic Strength -0.28%
Up 3 Days in a Row Strength -0.28%
Upper Bollinger Band Touch Strength -0.28%

Older signals for SLP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Simulations Plus, Inc. designs and develops pharmaceutical simulation software for use in the pharmaceutical research and in the education of pharmacy and medical students. The company's products include ADMET Predictor, a computer program that takes molecular structures as inputs and predicts their properties; MedChem Designer, a molecule drawing program or sketcher; MedChem Studio, a tool for data mining and designing new drug-like molecules by medicinal and computational chemists; DDDPlus, which simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives contained in tablets and capsules; and GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals. It also develops and sells Abbreviate!, a productivity software program, as well as offers consulting and contract research services to the pharmaceutical industry. The company operates in North America, Europe, Asia, and South America. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.
Pharmaceutical Industry Pharmacy Pharmacology Health Sciences Pharmacokinetics Pharmaceutical Sciences Medicinal Chemistry Simulation Software Data Mining Pharmaceutical Research Pharmacodynamics Contract Research Services
Is SLP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 25.08
52 Week Low 16.7
Average Volume 45,017
200-Day Moving Average 20.2945
50-Day Moving Average 21.8614
20-Day Moving Average 23.2175
10-Day Moving Average 24.011
Average True Range 0.7021
ADX 27.68
+DI 27.3212
-DI 12.3478
Chandelier Exit (Long, 3 ATRs ) 22.9737
Chandelier Exit (Short, 3 ATRs ) 23.5763
Upper Bollinger Band 25.0934
Lower Bollinger Band 21.3416
Percent B (%b) 0.87
BandWidth 16.159363
MACD Line 0.7829
MACD Signal Line 0.6933
MACD Histogram 0.0896
Fundamentals Value
Market Cap 424.4 Million
Num Shares 17.2 Million
EPS 0.31
Price-to-Earnings (P/E) Ratio 79.39
Price-to-Sales 13.07
Price-to-Book 11.31
PEG Ratio 2.59
Dividend 0.20
Dividend Yield 0.81%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.05
Resistance 3 (R3) 26.05 25.56 25.81
Resistance 2 (R2) 25.56 25.20 25.57 25.73
Resistance 1 (R1) 25.09 24.97 24.85 25.09 25.65
Pivot Point 24.60 24.60 24.48 24.61 24.60
Support 1 (S1) 24.13 24.24 23.89 24.13 23.57
Support 2 (S2) 23.64 24.01 23.65 23.49
Support 3 (S3) 23.17 23.64 23.41
Support 4 (S4) 23.17